Atossa Genetics ROE 2012-2025 | ATOS
Current and historical return on equity (ROE) values for Atossa Genetics (ATOS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Atossa Genetics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $-0.03B | $0.06B | -41.79% |
| 2025-03-31 | $-0.03B | $0.07B | -35.86% |
| 2024-12-31 | $-0.03B | $0.07B | -32.15% |
| 2024-09-30 | $-0.03B | $0.07B | -32.63% |
| 2024-06-30 | $-0.03B | $0.08B | -29.30% |
| 2024-03-31 | $-0.03B | $0.09B | -31.58% |
| 2023-12-31 | $-0.03B | $0.09B | -29.48% |
| 2023-09-30 | $-0.03B | $0.10B | -26.73% |
| 2023-06-30 | $-0.03B | $0.11B | -26.96% |
| 2023-03-31 | $-0.03B | $0.11B | -23.09% |
| 2022-12-31 | $-0.03B | $0.12B | -21.30% |
| 2022-09-30 | $-0.03B | $0.12B | -18.98% |
| 2022-06-30 | $-0.02B | $0.13B | -16.18% |
| 2022-03-31 | $-0.02B | $0.14B | -15.77% |
| 2021-12-31 | $-0.02B | $0.14B | -14.92% |
| 2021-09-30 | $-0.03B | $0.14B | -24.78% |
| 2021-06-30 | $-0.03B | $0.14B | -32.40% |
| 2021-03-31 | $-0.02B | $0.14B | -49.73% |
| 2020-12-31 | $-0.02B | $0.03B | -157.14% |
| 2020-09-30 | $-0.01B | $0.01B | -123.81% |
| 2020-06-30 | $-0.01B | $0.01B | -110.64% |
| 2020-03-31 | $-0.02B | $0.01B | -112.28% |
| 2019-12-31 | $-0.02B | $0.01B | -104.62% |
| 2019-09-30 | $-0.02B | $0.02B | -104.92% |
| 2019-06-30 | $-0.02B | $0.02B | -112.28% |
| 2019-03-31 | $-0.03B | $0.02B | -188.68% |
| 2018-12-31 | $-0.02B | $0.01B | -235.90% |
| 2018-09-30 | $-0.02B | $0.01B | -248.65% |
| 2018-06-30 | $-0.02B | $0.01B | -303.45% |
| 2018-03-31 | $-0.01B | $0.01B | -244.44% |
| 2017-12-31 | $-0.01B | $0.01B | -293.33% |
| 2017-09-30 | $-0.01B | $0.00B | -436.36% |
| 2017-06-30 | $-0.01B | $0.00B | -307.69% |
| 2017-03-31 | $-0.01B | $0.00B | -233.33% |
| 2016-12-31 | $-0.01B | $0.00B | -200.00% |
| 2016-09-30 | $-0.01B | $0.01B | -240.00% |
| 2016-06-30 | $-0.01B | $0.00B | -273.68% |
| 2016-03-31 | $-0.01B | $0.00B | -186.67% |
| 2015-12-31 | $-0.02B | $0.00B | -166.67% |
| 2015-09-30 | $-0.02B | $0.01B | -156.10% |
| 2015-06-30 | $-0.02B | $0.01B | -127.66% |
| 2015-03-31 | $-0.02B | $0.01B | -115.38% |
| 2014-12-31 | $-0.01B | $0.01B | -88.89% |
| 2014-09-30 | $-0.01B | $0.02B | -67.69% |
| 2014-06-30 | $-0.01B | $0.02B | -77.42% |
| 2014-03-31 | $-0.01B | $0.02B | -92.31% |
| 2013-12-31 | $-0.01B | $0.01B | -126.32% |
| 2013-09-30 | $-0.01B | $0.01B | -137.50% |
| 2013-06-30 | $-0.01B | $0.01B | -139.13% |
| 2013-03-31 | $-0.01B | $0.01B | -160.00% |
| 2012-12-31 | $-0.01B | $0.01B | -250.00% |
| 2012-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.100B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.456B | 22.32 |
| Intuitive Surgical (ISRG) | United States | $170.011B | 70.47 |
| IDEXX Laboratories (IDXX) | United States | $51.341B | 53.43 |
| Edwards Lifesciences (EW) | United States | $47.714B | 31.62 |
| Alcon (ALC) | Switzerland | $40.175B | 26.97 |
| IQVIA Holdings (IQV) | United States | $31.919B | 18.04 |
| DexCom (DXCM) | United States | $29.851B | 44.78 |
| Mettler-Toledo (MTD) | United States | $26.465B | 31.41 |
| STERIS (STE) | Ireland | $24.483B | 26.06 |
| Waters (WAT) | United States | $17.627B | 24.21 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.949B | 0.00 |
| Hologic (HOLX) | United States | $14.820B | 16.06 |
| Penumbra (PEN) | United States | $10.374B | 75.78 |
| Globus Medical (GMED) | United States | $8.357B | 19.28 |
| Sysmex ADR (SSMXY) | Japan | $8.133B | 25.84 |
| Masimo (MASI) | United States | $7.782B | 26.19 |
| Teleflex (TFX) | United States | $5.623B | 9.08 |
| Glaukos (GKOS) | United States | $5.379B | 0.00 |
| TransMedics (TMDX) | United States | $3.927B | 59.68 |
| Integer Holdings (ITGR) | United States | $3.800B | 18.96 |
| LivaNova (LIVN) | United Kingdom | $3.090B | 17.68 |
| Alphatec Holdings (ATEC) | United States | $2.375B | 0.00 |
| Veracyte (VCYT) | United States | $2.287B | 31.60 |
| PROCEPT BioRobotics (PRCT) | United States | $2.254B | 0.00 |
| Artivion (AORT) | United States | $2.078B | 104.83 |
| Nihon Kohden (NHNKY) | Japan | $1.950B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $1.864B | 17.43 |
| Integra LifeSciences Holdings (IART) | United States | $1.150B | 6.59 |
| Pulse Biosciences (PLSE) | United States | $1.138B | 0.00 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| IRadimed (IRMD) | United States | $0.925B | 44.87 |
| Tandem Diabetes Care (TNDM) | United States | $0.827B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.537B | 9.49 |
| Treace Medical Concepts (TMCI) | United States | $0.470B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 3.66 |
| AngioDynamics (ANGO) | United States | $0.398B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.396B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.70 |
| RxSight (RXST) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.290B | 20.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.282B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.280B | 0.00 |
| 908 Devices (MASS) | United States | $0.228B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.177B | 0.00 |
| Accuray (ARAY) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.136B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| InspireMD (NSPR) | United States | $0.103B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.091B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.48 |